These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22679336)

  • 1. Marker-of-self becomes marker-of-senescence.
    Sosale N; Discher DE
    Blood; 2012 Jun; 119(23):5343-4. PubMed ID: 22679336
    [No Abstract]   [Full Text] [Related]  

  • 2. CD47 functions as a molecular switch for erythrocyte phagocytosis.
    Burger P; Hilarius-Stokman P; de Korte D; van den Berg TK; van Bruggen R
    Blood; 2012 Jun; 119(23):5512-21. PubMed ID: 22427202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
    Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS
    Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231
    [No Abstract]   [Full Text] [Related]  

  • 4. Less phagocytosis of viral vectors by tethering with CD47 ectodomain.
    Alyami EM; Tarar A; Peng CA
    J Mater Chem B; 2021 Dec; 10(1):64-77. PubMed ID: 34846059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRPα-CD47 Immune Checkpoint Blockade in Anticancer Therapy.
    Veillette A; Chen J
    Trends Immunol; 2018 Mar; 39(3):173-184. PubMed ID: 29336991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer immunotherapy targeting the CD47/SIRPα axis.
    Weiskopf K
    Eur J Cancer; 2017 May; 76():100-109. PubMed ID: 28286286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potentiating effect of hTFPI in the presence of hCD47 reduces the cytotoxicity of human macrophages.
    Jung SH; Hwang JH; Kim SE; Young Kyu K; Park HC; Lee HT
    Xenotransplantation; 2017 May; 24(3):. PubMed ID: 28393401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system.
    Okazawa H; Motegi S; Ohyama N; Ohnishi H; Tomizawa T; Kaneko Y; Oldenborg PA; Ishikawa O; Matozaki T
    J Immunol; 2005 Feb; 174(4):2004-11. PubMed ID: 15699129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRPα-Antibody Fusion Proteins Selectively Bind and Eliminate Dual Antigen-Expressing Tumor Cells.
    Piccione EC; Juarez S; Tseng S; Liu J; Stafford M; Narayanan C; Wang L; Weiskopf K; Majeti R
    Clin Cancer Res; 2016 Oct; 22(20):5109-5119. PubMed ID: 27126995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer.
    Matlung HL; Szilagyi K; Barclay NA; van den Berg TK
    Immunol Rev; 2017 Mar; 276(1):145-164. PubMed ID: 28258703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering macrophages to eat cancer: from "marker of self" CD47 and phagocytosis to differentiation.
    Alvey C; Discher DE
    J Leukoc Biol; 2017 Jul; 102(1):31-40. PubMed ID: 28522599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications.
    Chao MP; Weissman IL; Majeti R
    Curr Opin Immunol; 2012 Apr; 24(2):225-32. PubMed ID: 22310103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47-SIRPα Checkpoint Inhibition.
    Treffers LW; Ten Broeke T; Rösner T; Jansen JHM; van Houdt M; Kahle S; Schornagel K; Verkuijlen PJJH; Prins JM; Franke K; Kuijpers TW; van den Berg TK; Valerius T; Leusen JHW; Matlung HL
    Cancer Immunol Res; 2020 Jan; 8(1):120-130. PubMed ID: 31690649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenic Dendritic Cells Survey Red Blood Cells for Missing Self-CD47 to Trigger Adaptive Immune Responses.
    Yi T; Li J; Chen H; Wu J; An J; Xu Y; Hu Y; Lowell CA; Cyster JG
    Immunity; 2015 Oct; 43(4):764-75. PubMed ID: 26453377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phagocytic signaling: you can touch, but you can't eat.
    Kinchen JM; Ravichandran KS
    Curr Biol; 2008 Jun; 18(12):R521-4. PubMed ID: 18579095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self inhibition of phagocytosis: the affinity of 'marker of self' CD47 for SIRPalpha dictates potency of inhibition but only at low expression levels.
    Tsai RK; Rodriguez PL; Discher DE
    Blood Cells Mol Dis; 2010 Jun; 45(1):67-74. PubMed ID: 20299253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway.
    Matozaki T; Murata Y; Okazawa H; Ohnishi H
    Trends Cell Biol; 2009 Feb; 19(2):72-80. PubMed ID: 19144521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CD47 as a marker of self on red blood cells.
    Oldenborg PA; Zheleznyak A; Fang YF; Lagenaur CF; Gresham HD; Lindberg FP
    Science; 2000 Jun; 288(5473):2051-4. PubMed ID: 10856220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the mechanism of CD47 targeting in cancer.
    Zhao XW; Matlung HL; Kuijpers TW; van den Berg TK
    Proc Natl Acad Sci U S A; 2012 Oct; 109(42):E2843; author reply E2844-5. PubMed ID: 22923695
    [No Abstract]   [Full Text] [Related]  

  • 20. A new way to keep immune cells in check.
    Hagmann M
    Science; 2000 Jun; 288(5473):1945-6. PubMed ID: 10877706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.